MedTech News
.................... by Andrew Celentano
Study finds stress-related nerves may fuel pancreatic cancer growth
Oregon Health & Science University researchers have found that certain nerves that play an integral role in the body’s “fight or flight” stress response can support pancreatic tumor growth.
‘Mini hearts’ show COVID-19 virus directly infects heart tissue
Researchers from the Centenary Institute and the University of Technology Sydney (UTS) have developed a human heart cell model demonstrating that the virus that causes COVID-19 (SARS-CoV-2) can directly infect heart tissue, providing new insight into why some people experience serious heart complications during and after infection.
Injectable “satellite livers” could offer an alternative to liver transplantation
The engineered tissue grafts could take on the liver’s function and help thousands of people with liver failure.
Asieris: CEVIRA Approved in China as First-in-Class Non-Invasive Therapy for Cervical Precancerous Lesions
OSLO, Norway, March 3, 2026 /PRNewswire/ — Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) communicated today that its core product APL-1702 (trade name: CEVIRA®), has received the Drug Registration Certificate from China’s National Medical Products Administration (NMPA), enabling commercial launch in China.
Hubly Surgical awarded Breakthrough Technology Designation for Neurosurgical Products with Premier, Inc.
LILSE, Ill., March 3, 2026 /PRNewswire/ — Hubly Surgical has been awarded a Breakthrough Technology Designation for Neurosurgical Products with Premier, Inc. Premier offers Breakthrough Technology designations to innovations that offer a major advantage in terms of patient safety, clinical outcomes and operational efficiencies.
Perimeter Medical Imaging AI’s ‘Claire’ Becomes First FDA-approved AI-Enabled Imaging Device for Breast Cancer Surgery
TORONTO and DALLAS, March 3, 2026 /PRNewswire/ – Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) (“Perimeter” or the “Company”), a commercial-stage medical technology company, announced today that it has received U.S. Food and Drug Administration (“FDA”) premarket approval (“PMA”) for Claire™ (formerly the Perimeter OCT B-Series with ImgAssist AI 2.0), the first AI-enabled imaging device approved in the United States for intraoperative breast cancer margin assessment.
Novel prosthetic design combines AI and 3D printing to improve fit
A new, fully customizable 3D printed socket design is set to transform the prosthetics industry.
Precision tumor imaging with a fluorescence probe and engineered enzymes—selective activation enables easy visibility
In tests on mice, we delivered a special enzyme to tumors and used a fluorescence probe that only turns on when that enzyme is present,